DaVita Appoints Dr. John Moran as Vice President, Clinical Affairs - Home Therapies
DENVER, Jan 19, 2010 (BUSINESS WIRE) -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced the appointment of Dr. John Moran as Vice President of Clinical Affairs - Home Therapies. Dr. Moran will be responsible for managing the clinical aspects of the home dialysis modalities offered to DaVita's approximately 117,000 patients.
"Dr. Moran is a highly accomplished and respected nephrologist, and has been internationally recognized for his work in the advancement of home therapies for dialysis patients," said Allen R. Nissenson, MD, FACP, Chief Medical Officer for DaVita(R). "We are thrilled to have him join the DaVita Village and are confident that his outstanding record as a kidney care specialist will help DaVita continue to provide high quality care to our patients."
Moran brings more than 33 years experience in the dialysis field. Since 2002, he has served as Chief Scientific Officer and later Senior Vice President of Clinical Affairs at Satellite Healthcare, with a special interest in the field of home peritoneal dialysis and hemodialysis as Corporate Medical Director for WellBound, Inc, a subsidiary of Satellite. Before joining Satellite, he was Chief Medical Officer of Vasca, Inc., where he was responsible for the clinical trials on the LifeSite(R) devices for vascular and peritoneal access. Previously, he was Global Medical Director of the Renal Division of Baxter Healthcare, and initiated and led the ADEMEX (ADEquacy of peritoneal dialysis in MEXico) study.
Currently he serves as a Consulting Professor in the School of Medicine at Stanford University. He is also a Fellow of the Royal Australasian College of Physicians and of the American Society of Nephrology.
Dr. Moran received his medical degree from the University of Melbourne in Australia.
DaVita is a registered trademark of DaVita Inc. All other trademarks are the property of their respective owners.
DaVita Inc., a Fortune 500(R) company, is a leading provider of kidney care in the United States, delivering dialysis services and education to patients with chronic kidney failure and end stage renal disease. As of September 30, 2009, DaVita operated or provided administrative services at 1,513 outpatient dialysis facilities and acute units in approximately 700 hospitals located in 43 states and the District of Columbia, serving approximately 117,000 patients. DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. The company's leadership development initiatives and corporate social responsibility efforts have been recognized by Fortune,Modern Healthcare, Newsweek and WorldBlu, among others. For more information, please visitwww.davita.com.
SOURCE: DaVita Inc.